drugset / Trial / NCT00817830

Cardiovascular Safety Study of Lodenafil Carbonate in Patients With Coronaropathy During Physical Effort

NCT00817830 ↗

Non-randomizedSingle-groupSingle-blindTreatment

Summary

The purpose of this study is to assess the safety of lodenafil carbonate in patients with coronaropathy, evaluating the response of the body facing physical effort, including both heart and respiratory components, with and without use of lodenafil carbonate 80mg.

Timeline

Start
2008-11
Primary completion
2009-05
Completion
2009-10

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty in patient recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject lodenafil Unknown 80 mg Oral